Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here
X

Going global: India’s big biosimilar move

4
Cipla is planning to build an $89m biosimilars manufacturing plant in Durban, South Africa. Image courtesy of Cipla.